Charles G Todderud

Title: The Innovations of Charles G. Todderud

Introduction

Charles G. Todderud is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of genetics, particularly in the identification and cloning of novel human genes. His work has implications for both therapeutics and diagnostics, showcasing the importance of innovation in medical research.

Latest Patents

Charles G. Todderud holds a patent for the identification and cloning of a novel human gene, RET16. This invention describes a newly discovered polynucleotide encoding a protein involved in the cell signaling cascade. The RET16 gene was cloned, isolated, and identified from TNF-alpha stimulated human microvascular endothelial cells, along with its mouse and rat orthologs. The patent also details the RET16 polypeptide sequence, expression vectors, host cells, agonists, antagonists, antisense molecules, and antibodies related to the polynucleotide and/or polypeptide. Furthermore, methods for screening modulators, particularly inhibitors, of the human RET16 protein are included, emphasizing the potential therapeutic applications of this discovery.

Career Highlights

Charles G. Todderud is associated with Bristol-Myers Squibb Company, where he continues to contribute to advancements in medical research. His work has been instrumental in understanding the complexities of intracellular signaling and its implications for human health.

Collaborations

Some of his notable coworkers include Joshua N. Finger and Jill Rillema, who have collaborated with him on various projects related to his research.

Conclusion

Charles G. Todderud's innovative work in the field of genetics exemplifies the critical role of inventors in advancing medical science. His contributions, particularly through his patent on the RET16 gene, highlight the potential for new therapeutic and diagnostic tools in healthcare.